| Price | 154 to 162 |
|---|---|
| GMP Rumors | ₹5 |
| Lot size | 92 |
| Issue size | ₹920 Cr |
| Allotment | 15-12-2025 |
| Listing | 17-12-2025 |
| Suggestion | May Apply |
| Allotment Status | Kfintech |
| Video |
BSE List Price : ₹155.60
NSE List Price : ₹158.00
| Category | Times |
|---|---|
| QIBs | 12.07x |
| HNIs | 15.93x |
| Retail | 3.32x |
| Total : 8.52x | |
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 92 | ₹14,904 |
| Retail Maximum | 13 | 1,196 | ₹193,752 |
| S-HNI Minimum | 14 | 1,288 | ₹208,656 |
| S-HNI Maximum | 67 | 6,164 | ₹998,568 |
| B-HNI Minimum | 68 | 6,256 | ₹1,013,472 |
Park Modi is an Indian private hospital chain with a capacity of around 3,000 beds as of September 30, 2024. The network consists of eight hospitals in Haryana, one in New Delhi, two in Punjab, and two in Rajasthan.
As of September 30, 2024, the company employed 891 doctors, 1,912 nurses, 671 medical professionals, and 1,761 support staff. Their skilled and experienced workforce continues to play a key role in the company’s growth.
During the six months ending September 30, 2024, the hospitals recorded 40,368 patients. They served approximately 73,284 patients in FY 2024, compared with 73,084 in FY 2023 and 62,106 in FY 2022.
| Period Ended | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2023 | ₹1272.18 | ₹955.37 | ₹228.19 | ₹1592.83 |
| 2024 | ₹1263.08 | ₹1041.66 | ₹152.01 | ₹1912.10 |
| 2025 | ₹1425.97 | ₹1139.30 | ₹213.22 | ₹2133.70 |
| September 2025 | ₹823.39 | ₹649.50 | ₹139.14 | ₹2320.93 |
Dr. Ajit Gupta
Dr. Ankit Gupta
• Extensive hospital presence with dominant regional position – One of North India’s major private healthcare providers and the leading player in Haryana by bed capacity.
• Broad medical service portfolio – Offers 30+ clinical specialties supported by NABH and NABL certifications, reinforcing reliability and patient confidence.
• Substantial contingent obligations – These liabilities and guarantees form a notable portion of the company’s net worth, and if triggered, could weaken its financial position.
• Potential credit rating pressure – Any downgrade may raise financing costs and adversely affect overall profitability.
Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by the Company and certain of the Subsidiaries.
Funding capital expenditure for development of new hospital and expansion of existing hospital by our certain Subsidiaries Park Medicity (NCR) and Blue Heavens, respectively.
Funding capital expenditure for purchase of medical equipment by the Company and our certain Subsidiaries, Blue Heavens and Ratangiri.
Unidentified inorganic acquisitions and general corporate purposes.
Park Medi World Ltd.
12, Meera Enclave Near Keshopur,
Bus Depot, Outer Ring Road,
New Delhi 110018, Delhi
New Delhi, New Delhi, 110018
Phone: + 91 124 696 000
Email: company.secretary@parkhospital.in
Website: http://www.parkhospital.in/
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: parkmedi.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
May Apply